306 related articles for article (PubMed ID: 11807441)
1. Economic analysis in dermatology.
Ellis CN; Reiter KL; Wheeler JR; Fendrick AM
J Am Acad Dermatol; 2002 Feb; 46(2):271-83. PubMed ID: 11807441
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and health economics: where is the link?
Jönsson B
Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
[TBL] [Abstract][Full Text] [Related]
3. The economic evaluation of health care.
Haas M; Hall J
Health Inf Manag; 1998 Dec-1999 Feb; 28(4):169-72. PubMed ID: 10387363
[TBL] [Abstract][Full Text] [Related]
4. Accounting for future costs in medical cost-effectiveness analysis.
Meltzer D
J Health Econ; 1997 Feb; 16(1):33-64. PubMed ID: 10167344
[TBL] [Abstract][Full Text] [Related]
5. Challenges in economic outcomes research.
Cook JR
Hepatology; 1999 Jun; 29(6 Suppl):23S-25S. PubMed ID: 10386079
[TBL] [Abstract][Full Text] [Related]
6. Cost and outcomes analysis.
King JT; Ratcheson RA
Neurosurg Clin N Am; 1998 Jul; 9(3):629-40. PubMed ID: 9668193
[TBL] [Abstract][Full Text] [Related]
7. Philosophical concerns regarding cost-effectiveness analyses.
Weiner BK
Med Hypotheses; 2010 Feb; 74(2):383-6. PubMed ID: 19651478
[TBL] [Abstract][Full Text] [Related]
8. Economic foundations of cost-effectiveness analysis.
Garber AM; Phelps CE
J Health Econ; 1997 Feb; 16(1):1-31. PubMed ID: 10167341
[TBL] [Abstract][Full Text] [Related]
9. Cost-benefit analyses in the health-care literature: don't judge a study by its label.
Zarnke KB; Levine MA; O'Brien BJ
J Clin Epidemiol; 1997 Jul; 50(7):813-22. PubMed ID: 9253393
[TBL] [Abstract][Full Text] [Related]
10. Accounting for the missing opportunity costs in incremental cost-outcome analysis.
Oliver A
Appl Health Econ Health Policy; 2002; 1(4):191-6. PubMed ID: 14619248
[TBL] [Abstract][Full Text] [Related]
11. Preferences for health outcomes and cost-utility analysis.
Torrance GW
Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluations and randomized trials in spinal disorders: principles and methods.
Korthals-de Bos I; van Tulder M; van Dieten H; Bouter L
Spine (Phila Pa 1976); 2004 Feb; 29(4):442-8. PubMed ID: 15094541
[TBL] [Abstract][Full Text] [Related]
13. The importance of patient preferences for comorbidities in cost-effectiveness analyses.
Harris RA; Nease RF
J Health Econ; 1997 Feb; 16(1):113-9. PubMed ID: 10167342
[TBL] [Abstract][Full Text] [Related]
14. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
[No Abstract] [Full Text] [Related]
15. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
Birch S; Gafni A
J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
[TBL] [Abstract][Full Text] [Related]
16. Theory and methods of economic evaluation of health care.
Johannesson M
Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
[No Abstract] [Full Text] [Related]
17. Economic considerations for the hepatologist.
Provenzale D
Hepatology; 1999 Jun; 29(6 Suppl):13S-17S. PubMed ID: 10386077
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls.
Bambha K; Kim WR
Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):519-26. PubMed ID: 15167152
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis from a societal perspective.
Johannesson M; O'Conor RM
Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
[TBL] [Abstract][Full Text] [Related]
20. Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
Labelle RJ; Hurley JE
J Health Econ; 1992 Oct; 11(3):259-77. PubMed ID: 10122539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
